If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
REPRODUCTIVE
HEALTH
EMJ Repro Health 2019 Suppl 1 • europeanmedical-journal.com
INSIDE
Overcoming Challenges in
Reproductive Health Applications
by Deploying More Sensitive and
Accurate Molecular Technologies
Overcoming Challenges in Reproductive Health
Applications by Deploying More Sensitive
and Accurate Molecular Technologies
Authors: Charlotte Brasch-Andersen,1 Doron M. Behar,2 Sandra Garcia Herrero,3
Carmen Rubio3
1. Department of Clinical Genetics, Odense University Hospital, University of
Southern Denmark, Odense, Denmark
2. Igentify, Haifa, Israel
3. IGENOMIX Paterna, Valencia, Spain
*Correspondence to Charlotte.B.Andersen@rsyd.dk
Disclosure: Dr Behar has declared that he is serving as the CEO of Igentify Ltd. and also owns
REPRODUCTIVE HEALTH EMJ Repro Health 2019 Suppl
Overcoming Challenges in Reproductive Health
INTRODUCTION In recent years, the introduction of
Current PGT-A techniques require an invasive embr
Table 1 continued. Traditional techniques New mo
related to the pathogenic locus, which requires a
of successful cell culture with failure rat
screening for trisomy 21, 18, and 13, as well as
required for this type of data analysis means tha
non-invasive, and greatly increase the diagnostic
Mol Life Sci. 2014;71(9):1761-74. 24. Zhao HC et
65. Henneman L et al. Responsible